As shown in Table 1, Fig. 1a and b, high expressions of ZIP5, ZIP10, ZIP12, ZIP13 and ZIP14 were significantly associated with unfavorable overall survival (OS) and progression-free survival (PFS) in ovarian cancer patients. This evidence concerns the gene SLC39A14 and ovarian cancer.